WednesdayFeb 02, 2022 2:06 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clients Company deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North America Company actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026 BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified health and wellness beverage and natural products company developing and manufacturing a diverse portfolio of alkaline, plant-based, and cannabinoid beverages and supplements for in-house brands and white-label clients alike. Founded in 2017, BevCanna…

Continue Reading

TuesdayFeb 01, 2022 2:20 pm

The Alternative Products Expo To Offer Important Networking Opportunities

The Alternative Products Expo arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives, vape products, energy…

Continue Reading

TuesdayFeb 01, 2022 1:41 pm

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market The company plans to launch new rare cannabinoid products in the first half of…

Continue Reading

MondayJan 31, 2022 12:39 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Offers a Glimpse into Company’s Unique Technology and Operations on EDGE Podcast

Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. White He provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technology Mr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ: LEXX), was recently featured on episode 234 of the EDGE Podcast. Hosted by Brandon C. White, an Angel Investor and Entrepreneur, Mr. Bunka shared insights into his professional journey while also sharing what…

Continue Reading

MondayJan 31, 2022 11:58 am

Sugarmade Inc. (SGMD) Watching Growing Support for Federal Cannabis Reform

NLR reports that bipartisan support for cannabis policies could reshape federal enforcement, set the stage for further state legalization GOP sponsorship of bills could mean greater likelihood of success SGMD’s strategic plan is centered on expanding end-market access as a central player in the growing California cannabis delivery marketplace As 2021 wound to a close, indications of bipartisan support for federal cannabis reform raised the hope that legislative progress may be made on the federal level in the coming year (https://cnw.fm/7FdWD). Companies operating in the cannabis space, including Sugarmade (OTC: SGMD), are watching closely to see if that hope is…

Continue Reading

FridayJan 28, 2022 10:00 am

Flora Growth Corp. (NASDAQ: FLGC) Names Cannabis Pioneer as Colombian Facility Advisor as Company Prepares for International Growth

Canada-based Flora Growth Corp. operates cannabis cultivation and extraction processes in-house at its Cosechemos lab and growth facility in central Colombia The company has been building a portfolio of cannabis and wellness products and obtaining a variety of licenses and GMP certifications as it establishes partnerships to economically distribute its portfolio worldwide Flora Growth recently announced the addition of pioneering cannabis genetics innovator Derek Pedro in an advisory role for its Cosechemos facility Pedro will help the company build on its more-than-190 product offerings with cannabis flower cultivation and distribution Cannabis cultivator and worldwide cannabidiol (“CBD”) brand builder Flora Growth…

Continue Reading

ThursdayJan 27, 2022 11:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Emphasizes Oral Cannabinoid Delivery Benefits Following SARS-CoV-2 Study

The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://cnw.fm/Aq36i) Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping cannabinoids are ineffective against preventing SARS-CoV-2, whereas oral delivery methods are effective Lexaria has been studying and researching the oral delivery of compounds using its patented DehydraTECH(TM) technology, which enhances bioavailability and absorption, requiring less heat than smoking or vaping and leaving the cannabinoid compounds undamaged Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, commented on an independent January 10 study headed…

Continue Reading

ThursdayJan 27, 2022 10:30 am

Sugarmade Inc.’s (SGMD) Progress in 2021 Leads to Strong Position in Growing Cannabis Space Sugarmade Inc.’s (SGMD) Progress in 2021 Leads to Strong Position in Growing Cannabis Space

NA legal cannabis market size projected to grow at CAGR of 16.6% from 2022 to 2028 More than 3,500 peer-reviewed scientific papers studying cannabis were published in 2020 alone SGMD reaches key objectives, seeing key growth in 2021 After a year of impressive progress and growth, Sugarmade (OTC: SGMD) has established an enviable position in the legal cannabis market, a sector that is expected to see an estimated 16.6% growth in the coming years (https://cnw.fm/jxVvI). “The North America legal cannabis market size was valued at USD 12.4 billion in 2021 and is projected to grow at a compound annual growth rate…

Continue Reading

ThursdayJan 27, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Gains Full Cannabis Licensing to Rise in Michigan’s Developing Recreational Use Market

Multi-state cannabis operator Red White & Bloom Brands is developing opportunities strategically in sizable cannabis markets such as Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts The company recently announced it has secured full licensing for manufacturing both medical and adult use cannabis products in Michigan, one of its key markets Red White & Bloom has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the state In Florida, Red White & Bloom settled a CAD$5.1 million debt at a favorable conversion price, granting the company an accounting gain of approximately CAD$2.3 million As Michigan…

Continue Reading

WednesdayJan 26, 2022 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market

The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029 InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoids It is shedding light on the potential of rare cannabinoids and laying the groundwork on how to tap into the industry’s growth It is projected that by 2025, the global cannabis market will be valued at around $146 billion, up from just $20.47 billion in 2020. This sector is experiencing tremendous growth, particularly considering that there are over one hundred known cannabinoids, including rare ones that are quickly…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000